Barclays
UHS icon

Barclays’s Universal Health Services UHS Stock Holding History

Barclays’s Portfolio UHS Stock Details UHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,000
Closed -$6.22M – 5635
2021
Q4 		$6.22M Buy
+48,000
New +$6.17M ﹤0.01% 1557
2020
Q2 		– Sell
-1,000
Closed -$99K – 6262
2020
Q1 		$99K Buy
1,000
+500
+100% +$63.3K ﹤0.01% 4810
2019
Q4 		$72K Buy
+500
New +$71.3K ﹤0.01% 5624
2019
Q2 		– Sell
-2,300
Closed -$308K – 7288
2019
Q1 		$308K Buy
2,300
+900
+64% +$119K ﹤0.01% 4512
2018
Q4 		$163K Hold
1,400
– – ﹤0.01% 4720
2018
Q3 		$179K Sell
1,400
-500
-26% -$61.4K ﹤0.01% 5099
2018
Q2 		$212K Buy
1,900
+100
+6% +$11.7K ﹤0.01% 4677
2018
Q1 		$213K Sell
1,800
-900
-33% -$107K ﹤0.01% 4781
2017
Q4 		$306K Sell
2,700
-14,300
-84% -$1.53M ﹤0.01% 4327
2017
Q3 		$1.89M Sell
17,000
-5,900
-26% -$664K ﹤0.01% 2416
2017
Q2 		$2.8M Buy
22,900
+22,200
+3,171% +$2.64M ﹤0.01% 1958
2017
Q1 		$87K Buy
700
+500
+250% +$59.1K ﹤0.01% 4983
2016
Q4 		$21K Sell
200
-1,400
-88% -$166K ﹤0.01% 5604
2016
Q3 		$197K Buy
1,600
+400
+33% +$50.7K ﹤0.01% 3983
2016
Q2 		$161K Sell
1,200
-4,600
-79% -$607K ﹤0.01% 4085
2016
Q1 		$719K Buy
5,800
+3,200
+123% +$360K ﹤0.01% 2823
2015
Q4 		$309K Sell
2,600
-3,200
-55% -$391K ﹤0.01% 3562
2015
Q3 		$719K Sell
5,800
-10,800
-65% -$1.5M ﹤0.01% 3033
2015
Q2 		$2.36M Buy
16,600
+8,300
+100% +$1.04M ﹤0.01% 2107
2015
Q1 		$971K Sell
8,300
-26,000
-76% -$2.88M ﹤0.01% 3007
2014
Q4 		$3.81M Buy
34,300
+31,300
+1,043% +$3.29M ﹤0.01% 1934
2014
Q3 		$312K Sell
3,000
-2,900
-49% -$308K ﹤0.01% 4368
2014
Q2 		$561K Buy
5,900
+4,200
+247% +$363K ﹤0.01% 3862
2014
Q1 		$139K Sell
1,700
-163,600
-99% -$13.2M ﹤0.01% 5145
2013
Q4 		$13.4M Sell
165,300
-3,100
-2% -$248K 0.01% 1038
2013
Q3 		$12.5M Buy
168,400
+92,900
+123% +$6.48M 0.01% 984
2013
Q2 		$5.05M Buy
+75,500
New +$4.99M 0.01% 1619

Other funds holding UHS

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's UHS Position: Q1 2026 in Review

Barclays increased its Universal Health Services (UHS) stake by 5.9% in Q1 2026, buying an estimated $1.52M and bringing the position to 132,553 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #1023.

Barclays first reported a position in UHS in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.2M in Q3 2024. 652 funds tracked by Wall St. Rank hold UHS as of Q1 2026.

  • Barclays held 132,553 shares of Universal Health Services worth $23.7M as of Q1 2026.
  • Barclays bought 7,382 Universal Health Services shares in Q1 2026, an estimated $1.52M.
  • Universal Health Services made up 0.01% of Barclays's portfolio in Q1 2026, its #1023 holding.
  • Barclays first reported a position in Universal Health Services in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Universal Health Services position peaked at $43.2M in Q3 2024.
  • 652 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.